Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Primers for detecting SARS-CoV-2 novel coronavirus and kit thereof, detection method and applications

A sars-cov-2 and kit technology, applied in the field of primers for SARS-CoV-2 detection, can solve the problems of 30% to 50%, limiting the wide application of nucleic acid detection, and high false negative rate

Pending Publication Date: 2021-09-28
OXFORD UNIV SUZHOU SCI & TECH CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently, methods for detecting SARS-CoV-2 are based either on the detection of viral RNA itself using reverse transcription real-time polymerase chain reaction (RT-qPCR) technology, or on specific immunoglobulins IgM and IgG, these existing methods require laboratories to be equipped with specialized detection equipment, operated by skilled scientists and technicians, and take a long time (about 2 hours or more), therefore, limiting the use of nucleic acid detection in the current global COVID-19 -Wide application in the huge testing demand of the 19 pandemic
In addition, the existing nucleic acid detection reagents also have the problem of high false negative rate (positive detection rate can be as low as 30% to 50%)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primers for detecting SARS-CoV-2 novel coronavirus and kit thereof, detection method and applications
  • Primers for detecting SARS-CoV-2 novel coronavirus and kit thereof, detection method and applications
  • Primers for detecting SARS-CoV-2 novel coronavirus and kit thereof, detection method and applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1. Design of specific primer sequences for detection

[0046] The inventors of the present application designed highly specific primer sequences for the SARS-CoV-2 virus genome sequence (GenBank, NC_045512.2) published in NCBI. In particular, the present application designed 4 primer sets, namely O117, S17, N1 and N15 primer sets, which are specific to different regions in the viral gene sequence. Each primer set contains 6 primers, namely forward primer F3, reverse primer B3, forward inner primer FIP, reverse inner primer BIP, forward loop primer LF and reverse loop primer LB. Primers were designed using the primer design software PrimerExplorer ( http: / / primerexplorer.jp / e / ) as an auxiliary tool.

[0047] The design of the primers in this application takes into account the key characteristics that are highly related to the SARS-CoV-2 virus RNA itself, so as to ensure the high specificity, accuracy and sensitivity of each primer set. SARS-CoV-2 is a single-s...

Embodiment 2

[0055] Example 2: In vitro detection simulation experiment of SARS-CoV-2 virus synthetic DNA fragment target

[0056] This embodiment is used to test the primers of the present application for in vitro (invitro) detection simulation experiments of SARS-CoV-2 synthetic DNA fragments.

[0057] 1. DNA target synthesis and purification

[0058] In order to carry out simulation experiments, DNA fragments targeting four relevant regions of N, S, and Orf1ab target genes were designed, and each fragment contained the T7 promoter for in vitro transcription, namely N1-T7, N15-T7, S17-T7 , O117-T7, its sequence (SEQ ID NO.25-28) is shown in Table 2. Human β-actin primer (Poon LLM, et al.Detection of human influenza A viruses by loop-mediated isothermamplification.Journal of Clinical Microbiology 43,427-430 (2005)) was used as a negative control, and its sequence (SEQ ID NO.29 -32) as shown in Table 3. All designed primers and DNA fragments, as well as the positive control plasmid (201...

Embodiment 3

[0083] Example 3: In vitro simulation experiment of SARS-CoV-2 virus RNA target

[0084] This embodiment is an in vitro simulation experiment for testing the primers of the present application for detecting SARS-CoV-2 viral RNA.

[0085] 1. Acquisition and purification of RNA targets

[0086] Use HiScribe TM T7 High Yield RNA Synthesis Kit (HiScribe TM T7 High Yield RNASynthesis Kit, New England Biolabs, UK), the DNA sequence of T7_N, T7_S and T7_O synthesized by IDT described in Example 1 was transcribed in vitro.

[0087] The transcripts were purified using RNeasy Mini Kit (Qiagen, UK), and the concentration and quality of RNA were measured using NanoDrop nucleic acid detector.

[0088] The copy number of each target RNA was determined based on its molecular weight, and diluted to 200,000 copies / μl, 200 copies / μl, 20 copies / μl, and 2 copies / μl for subsequent experiments.

[0089] Using Fast DNA TM The SPIN kit (MP Biomedicals) was used to purify the whole human genome ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to primers and a kit for SARS-CoV-2 gene amplification. The primers and kit are combined with a gene amplification system including LAMP or RT-LAMP and the like, can quickly, simply and highly specifically determine COVID-19 patients and asymptomatic carriers and judge whether an SARS-CoV-2 virus exists in an environmental sample or not without complicated instruments. Optionally, a test result can be read by naked eyes, so that large-scale SARS-CoV-2 virus screening is achieved. An application method and applications of the primers and the kit are further provided.

Description

technical field [0001] This application relates to primers for nucleic acid detection and applications thereof, in particular to primers, primer sets, kits, detection methods and applications for SARS-CoV-2 detection. Background technique [0002] The new coronavirus SARS-CoV-2 (also known as 2019-nCoV, HCoV-19, hereinafter referred to as "new coronavirus") that is currently prevalent in the world has caused a large number of people to be infected with new coronavirus pneumonia COVID-19 (hereinafter referred to as "" COVID-19"). Based on epidemiological investigations, the incubation period of COVID-19 is 1 to 14 days, mostly 3 to 7 days. The main symptoms are fever, dry cough, and fatigue. Severe patients often have dyspnea and / or hypoxemia one week after the onset. In severe cases, it can rapidly progress to acute respiratory distress syndrome, septic shock, difficult-to-correct metabolic acidosis, coagulation dysfunction, and multiple organ failure. To curb the spread o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/70C12Q1/6844C12N15/11
CPCC12Q1/701C12Q1/6844C12Q2531/119C12Q2521/107C12N15/11C12Q1/70C12Q1/68Y02A50/30
Inventor 崔占峰黄巍王允王珲
Owner OXFORD UNIV SUZHOU SCI & TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com